General Information of the Compound
| Compound ID |
CP0545487
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(5R)-4-[2-[(2S)-2-(4-chlorophenyl)-3-(propan-2-ylamino)propanoyl]-2,6-diazaspiro[3.3]heptan-6-yl]-5-methyl-6,8-dihydro-5H-pyrido[2,3-d]pyrimidin-7-one
Show/Hide
|
||||||||||||||||||
| Formula |
C25H31ClN6O2
|
||||||||||||||||||
| Molecular Weight |
483.016
|
||||||||||||||||||
| Canonical SMILES |
CC(C)NC[C@@H](C(=O)N1CC2(C1)CN(C2)c1ncnc2NC(=O)C[C@@H](C)c12)c1ccc(Cl)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C25H31ClN6O2/c1-15(2)27-9-19(17-4-6-18(26)7-5-17)24(34)32-12-25(13-32)10-31(11-25)23-21-16(3)8-20(33)30-22(21)28-14-29-23/h4-7,14-16,19,27H,8-13H2,1-3H3,(H,28,29,30,33)/t16-,19-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
GPRORMBDCPTVHB-VQIMIIECSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00845, RAC-alpha serine/threonine-protein kinase
Protein ID: PT01131, RAC-beta serine/threonine-protein kinase
Protein ID: PT01022, RAC-gamma serine/threonine-protein kinase